1.Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008;246(03):697–722.
2.Matsuguma H,Mori K,Nakahara R, et al. Characteristics of subsolid pulmonary nodules showing growth during follow-up with CT scanning. Chest 2013;143(02):436–443.
3.Chang B, Hwang JH, Choi YH, et al. Natural history of pure ground glass opacity lung nodules detected by low-dose CT scan. Chest 2013;143(01):172–178.
4.Silva M,Sverzellati N,Manna C, et al. Long-term surveillance of ground-glass nodules: evidence from the MILD trial. J Thorac Oncol 2012;7(10):1541–1546.
5.Kitami A, Sano F, Hayashi S, Suzuki K, Uematsu S, Kamio Y, et al. Correlation between histological invasiveness and the computed tomography value in pure ground-glass nodules. Surg Today. 2016;46:593-8.
6.Lee GD, Park CH, Park HS, Byun MK, Lee IJ, Kim TH, et al. Lung adenocarcinoma invasiveness risk in pure ground-glass opacity lung nodules smaller than 2 cm. Thorac Cardiovasc Surg. 2019;67:321-8.
7.Heidinger BH, Anderson KR, Nemec U, Costa DB, Gangadharan SP, VanderLaan PA, etal. Lung adenocarcinoma manifesting as pure ground-glass nodules: correlating CT size, volume, density, and roundness with histopathologic invasion and size. J Thorac Oncol. 2017;12:1288-98.
8.Nelson DB, Godoy MCB, Benveniste MF, Shewale JB, Spicer JD, Mitchell KG, et al. Clinicoradiographic predictors of aggressive biology in lung cancer with ground glass components. Ann Thorac Surg. 2018;106:235-41.
9.Sun F, Xi J, Zhan C, Yang X, Wang L, Shi Y, et al. Ground glass opacities: imaging, pathology, and gene mutations. J Thorac Cardiovasc Surg. 2018;156:808-13.
10.Antonoff MB. The search for reliable markers of ground glass opacity prognosis: the truth remains largely unknown. J Thorac Cardiovasc Surg. 2018;156:814-5.
11.Rami-Porta R, Bolejack V, Crowley J, Ball D, Kim J, Lyons G, et al. The IASLC lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol. 2015;10:990-1003.
12.Lackey A, Donington JS. Surgical management of lung cancer. Semin Intervent Radiol 2013; 30 (2): 133–40.
13.Oh JY, Kwon SY, Yoon HI et al. Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT. Lung Cancer 2007; 55 (1): 67–73.
14.Lee SM, Park CM, Goo JM et al. Transient part-solid nodules detected at screening thin-section CT for lung cancer: Comparison with persistent part-solid nodules. Radiology 2010; 255 (1): 242–51.
15.Lee SM, Park CM, Goo JM, Lee HJ, Wi JY, Kang CH. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: Differentiation by using CT features. Radiology 2013; 268 (1): 265–73.
16.Eguchi T, Yoshizawa A, Kawakami S et al. Tumor size and computed tomography attenuation of pulmonary pure ground-glass nodules are useful for predicting pathological invasiveness. PLOS One 2014; 9 (5): e97867.
17.Li M, Wang Y, Chen Y, Zhang Z. Identification of preoperative prediction factors of tumor subtypes for patients with solitary ground-glass opacity pulmonary nodules. J Cardiothorac Surg 2018; 13 (1): 9.
18.Moon Y, Park JK, Lee KY, Ahn S, Shin J. Predictive factors for invasive adenocarcinoma in patients with clinical non-invasive or minimally invasive lung cancer. J Thorac Dis 2018; 10 (11): 6010–9.
19.Li Q, Fan L, Cao ET, Li QC, Gu YF, Liu SY. Quantitative CT analysis of pulmonary pure ground-glass nodule predicts histological invasiveness. Eur J Radiol 2017; 89: 67–71.
20.Zhao W, Xu Y, Yang Z et al. Development and validation of a radiomics nomogram for identifying invasiveness of pulmonary adenocarcinomas appearing as subcentimeter ground-glass opacity nodules. Eur J Radiol 2019; 112: 161–8.
21. Eguchi T, Kadota K, Park BJ, et al. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know. Semin Thorac Cardiovasc Surg 2014;26:210-22.
22.Asamura H. Role of limited sublobar resection for early-stage lung cancer: steady progress. J Clin Oncol 2014;32(23):2403–2404.
23.Nakamura K, Saji H, Nakajima R, Okada M, Asamura H, Shibata T, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol. 2010;40:271–4.
24.Aokage K, Saji H, Suzuki K, Mizutani T, Katayama H, Shibata T, et al. A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211). Gen Thorac Cardiovasc Surg. 2017;65:267–72.
25.Sim HJ, Choi SH, Chae EJ, et al. Surgical management of pulmonary adenocarcinoma presenting as a pure ground glass nodule. Eur J Cardiothorac Surg 2014;46:632-6; discussion 636. 26.Yoshida J, Nagai K, Yokose T, et al. Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg 2005;129:991-6